MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025
MAIA Biotechnology, Inc., (NYSE American: MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that an abstract ...
Crain's Chicago Business4d
Maia Bio touts two advances for its lead cancer drug in development
THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...
TipRanks on MSN5d
MAIA Biotechnology publishes preclinical data for telomere-targeting THIO dimer
MAIA Biotechnology (MAIA) announced the publication of preclinical data for its lead proprietary telomere-targeting THIO dimer in the ...
MAIA Biotechnology receives USAN Council approval for ‘Ateganosine’ name
MAIA Biotechnology (MAIA) announced that the United States Adopted Names Council has approved “ateganosine” as the nonproprietary name for its ...
Business Wire26d
MAIA Biotechnology to Initiate Phase 3 Pivotal Trial of THIO Sequenced with Checkpoint Inhibitor Compared with Chemotherapy Treatment in Advanced Non-Small Cell Lung Cancer ...
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing ...
Business Insider1mon
MAIA Biotechnology to sell 1.81M shares at $1.50 in private placement
MAIA Biotechnology (MAIA) announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 1,810,000 shares of common stock at a purchase price of $1.50 per ...
Business Wire1mon
MAIA Biotechnology Announces Private Placement of $2,715,000
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing ...
ETF Daily News7d
MAIA Biotechnology (MAIA) to Release Earnings on Thursday
10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever MAIA Biotechnology, Inc, a clinical stage biotechnology company, engages in ...
Yahoo Finance5d
MAIA Biotechnology, Inc. (MAIA)
CHICAGO, March 20, 2025--MAIA Biotechnology Announces Publication of Peer-Reviewed Study Featuring Potency and Potential of Novel THIO Prodrug CHICAGO, February 27, 2025--MAIA to Initiate Phase 3 ...